Abstract
We report a 65-year-old diabetic woman who developed Aspergillus niger endophthalmitis after cataract surgery. She presented 9 weeks after extracapsular cataract extraction with a black growth covering the cornea and moderate echoes in the vitreous on ultrasonography. After microbiological confirmation of fungal endophthalmitis, the patient received intravitreal amphoterecin B 5 micro g, topical natamycin 5% hourly, atropine 1% 3 times, and oral antifungal therapy. The patient was told the visual prognosis and was advised to have penetrating keratoplasty and vitrectomy, which she refused.
MeSH terms
-
Aged
-
Amphotericin B / therapeutic use
-
Antifungal Agents / therapeutic use
-
Aspergillosis / diagnosis
-
Aspergillosis / drug therapy
-
Aspergillosis / etiology*
-
Aspergillus niger / isolation & purification*
-
Atropine / therapeutic use
-
Cataract Extraction / adverse effects*
-
Cornea / microbiology
-
Endophthalmitis / diagnosis
-
Endophthalmitis / drug therapy
-
Endophthalmitis / microbiology*
-
Eye Infections, Fungal / diagnosis
-
Eye Infections, Fungal / drug therapy
-
Eye Infections, Fungal / etiology*
-
Female
-
Humans
-
Itraconazole / therapeutic use
-
Natamycin / therapeutic use
-
Vitreous Body / microbiology
Substances
-
Antifungal Agents
-
Itraconazole
-
Atropine
-
Amphotericin B
-
Natamycin